12 completed. 12 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 12 |
Follow Bacterial Pneumonia: new trials by email Literature Review of Bacterial Pneumonia trials Research Report on Bacterial Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients Kunamin®, Favipiravir, Enoxaparin - COVID-19 Respiratory Infection, FLU | Phase 3 | Completed | RAAS Nutritionals, LLC | 71 | 2021-05-29 | 2022-06-14 |
| Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia Omadacycline, Moxifloxacin - Community-acquired Pneumonia, Bacterial Pneumonia | Phase 3 | Completed | Paratek Pharmaceuticals Inc | 670 | 2021-02-25 | 2025-04-09 |
| Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Imipenem, Relebactam, Cilastatin - Bacterial Pneumonia | Phase 3 | Completed | Merck Sharp & Dohme LLC | 537 | 2015-11-24 | 2020-04-16 |
| Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13) Omadacycline, Moxifloxacin - Bacterial Pneumonia, Community-Acquired Infections | Phase 3 | Completed | Paratek Pharmaceuticals Inc | 774 | 2015-11-01 | 2019-01-16 |
| Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial Inhaled corticosteroid, Placebo - Bacterial Pneumonia, Viral Pneumonia | Phase 3 | Completed | Makerere University | 1010 | 2012-12-01 | 2015-10-27 |
| Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia Ceftaroline fosamil for Injection, IV Ceftriaxone, Placebo - Bacterial Pneumonia | Phase 3 | Completed | Forest Laboratories | 606 | 2008-01-01 | 2017-03-14 |
| Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia Ceftaroline fosamil for Injection, Ceftriaxone, Placebo - Bacterial Pneumonia | Phase 3 | Completed | Forest Laboratories | 622 | 2007-07-01 | 2017-03-14 |
| Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Telavancin, Vancomycin - Bacterial Pneumonia | Phase 3 | Completed | Cumberland Pharmaceuticals | 761 | 2005-02-01 | 2019-01-16 |
| Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Telavancin, Vancomycin - Bacterial Pneumonia | Phase 3 | Completed | Cumberland Pharmaceuticals | 771 | 2005-01-01 | 2019-01-16 |
| Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia Tigecycline, Levofloxacin - Community-Acquired Infections, Bacterial Pneumonia | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 434 | 2004-01-01 | 2013-02-08 |
| Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia tigecycline - Community Acquired Pneumonia, Bacterial Pneumonia | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 430 | 2003-11-01 | 2013-02-08 |
| Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia Tigecycline, Imipenem, Cilastatin - Bacterial Pneumonia | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 430 | 2003-07-01 | 2008-08-04 |
Pneumonia, Bacterial (12) · Community-Acquired Pneumonia (4) · Community-Acquired Infections (2) · Cross Infection (2) · Haemophilus Infections (2) · Common Cold (1) · Healthcare-Associated Pneumonia (1) · Influenza, Human (1) · Pneumonia (1) · Pneumonia, Viral (1)
Bacterial Infections (12) · Bacterial Infections and Mycoses (12) · Infections (12) · Lung Diseases (12) · Respiratory Tract Diseases (12) · Respiratory Tract Infections (12) · Pneumonia (11) · Community-Acquired Infections (4) · Disease Attributes (3) · Iatrogenic Disease (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Gram-Negative Bacterial Infections (2) · Pasteurellaceae Infections (2) · Virus Diseases (2)
Ceftriaxone (3) · Tigecycline (3) · Ceftaroline (2) · Cilastatin (2) · Clarithromycin (2) · Imipenem (2) · Injections (2) · Moxifloxacin (2) · Vancomycin (2) · omadacycline (2) · telavancin (2) · Acetaminophen (1) · Enoxaparin (1) · Lansoprazole (1) · Levofloxacin (1)
Wyeth is now a wholly owned subsidiary of Pfizer (3) · Cumberland Pharmaceuticals (2) · Forest Laboratories (2) · Paratek Pharmaceuticals Inc (2) · Makerere University (1) · Merck Sharp & Dohme LLC (1) · RAAS Nutritionals, LLC (1)
United States (5) · Bulgaria (4) · Hungary (4) · Poland (4) · Russia (4) · Ukraine (4) · Georgia (3) · Germany (3) · Romania (3) · Argentina (2) · Austria (2) · Brazil (2) · Croatia (2) · India (2) · Israel (2)
G. Ralph Corey, MD (2) · Amy Manley (1) · Grace Ndeezi, PhD (1) · IM Hoepelman, MD (1) · James K Tumwine, PhD (1) · Kieu Hoang (1) · Thomas M File, MD, MS (1)
PMID 18508226, PMID 21482570, PMID 23357290, PMID 24708675, PMID 25487791, PMID 26702925, PMID 27718118, PMID 29454592, PMID 30597021, PMID 34922058, PMID 18436554, PMID 18990531, PMID 19036672, PMID 19740418, PMID 21482566, PMID 21482568, PMID 22812672, PMID 30726692, PMID 31367741, PMID 32785589, PMID 33326848, PMID 34704389, PMID 35776862, PMID 37383243, PMID 37575994, PMID 41586496, PMID 42743113
2015 (1)